# US 2010/0168782 A1 · High specific gravity intragastric device

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0168782 A1
- Document ID: US20100168782A1
- Status: Published application
- Kind: A1
- Application number: 12/645,466
- Filed: 2009-12-22
- Published: 2010-07-01
- Earliest claimed: 2008-12-27
- Inventors: John Hancock
- Web page: https://patentgrep.com/patent/US20100168782A1

## CPC

- A61F 5/0036: {Intragastrical devices}
- A61F 5/003: {inflatable}
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)

## Abstract

The teachings are directed to an intragastric device comprising a flexible and expandable bladder having a predetermined shape upon expansion for contacting the antrum of the stomach of a subject. The device is designed to avoid passage of any part of the device beyond the pylorus and lower esophageal sphincter while the bladder is expanded during use. In these embodiments, the bladder can contain a high specific gravity material when expanded; wherein, the high specific gravity material contributes to an in vivo specific gravity of the device that ranges from about 1.2 g/ml to about 2.1 g/ml and functions to direct the device to the pyloric antrum of the subject during use of the device. Moreover, these embodiments can include a filling material comprising a biocompatible fluid component and a hydrogel component to make the device substantially leakproof and contribute to the in vivo specific gravity of the device.

## Claims

### Claim 1

An untethered, high specific gravity, antrum-based, intragastric device, comprising:
an expandable casing having a biocompatible outer surface and, upon expansion, a predetermined shape for contacting the antrum of the stomach of a subject; wherein,
the expanded casing has
a minimum, cross-sectional dimension of at least about 40 mm during operation of the device in the subject to avoid passage of any portion of the device through the lower esophageal sphincter or pyloric sphincter of the subject after expansion;
a maximum, cross-sectional dimension of the predetermined shape of about 80 mm for a positioning of the predetermined shape in the pyloric antrum of the subject;
and,
a high specific gravity material, wherein the high specific gravity material contributes to an in vivo specific gravity of the device that ranges from about 1.2 g/ml to about 2.1 g/ml, wherein the specific gravity functions to direct the device to the pyloric antrum of the subject during use of the device.

### Claim 2 (depends on 1)

The device of claim 1, wherein the casing comprises the high specific gravity material.

### Claim 3 (depends on 1)

The device of claim 1, wherein the outer surface of the casing comprises the high specific gravity material.

### Claim 4 (depends on 1)

The device of claim 1, wherein the casing encloses an inner compartment and has a sealable port in communication with the inner compartment for administering a fluid and expanding the casing in the stomach of a subject.

### Claim 5 (depends on 4)

The device of claim 4, wherein the inner compartment contains the high specific gravity material.

### Claim 6 (depends on 4)

The device of claim 4, wherein the inner compartment contains the high specific gravity material, and the high specific gravity material is integrated with the casing.

### Claim 7 (depends on 1)

The device of claim 1, wherein the high specific gravity material comprises a biocompatible fluid.

### Claim 8 (depends on 1)

The device of claim 1, wherein the high specific gravity material comprises a biocompatible fluid selected from the group consisting of a salt solution, a sugar solution, honey, a sugar alcohol solution, glycerin, or a combination thereof.

### Claim 9 (depends on 1)

The device of claim 1, wherein the high specific gravity material comprises a sugar alcohol solution.

### Claim 10 (depends on 1)

The device of claim 1, wherein the high specific gravity material comprises a solid component.

### Claim 11 (depends on 1)

The device of claim 1, wherein the high specific gravity material comprises a solid component, and an expansion of the solid component contributes to expansion of the casing.

### Claim 12 (depends on 1)

The device of claim 1, wherein the high specific gravity material comprises a solid component that is hygroscopic.

### Claim 13 (depends on 1)

The device of claim 1, wherein the high specific gravity material comprises a hydrogel.

### Claim 14 (depends on 1)

The device of claim 1, wherein the high specific gravity material comprises a biocompatible solid selected from the group consisting of a metal, a salt, a heavy polymer or a combination thereof.

### Claim 15 (depends on 1)

The device of claim 1, wherein the device has an in vivo specific gravity ranging from about 1.2 g/ml to about 1.5 g/ml.

### Claim 16 (depends on 1)

The device of claim 1, wherein the device has an in vivo specific gravity ranging from about 1.2 g/ml to about 1.3 g/ml.

### Claim 17 (depends on 1)

The device of claim 1, wherein the device has an in vivo specific gravity ranging from about 1.3 g/ml to about 1.6 g/ml.

### Claim 18 (depends on 1)

The device of claim 1, wherein a portion of the outer surface is compliant or substantially compliant with a surface of the antrum and has a durometer of at least about Shore 40A.

### Claim 19 (depends on 1)

The device of claim 1, wherein, the predetermined shape is designed to apply a pressure to the antrum to satiate hunger in the subject.

### Claim 20 (depends on 1)

The device of claim 1, wherein the expanded casing contains an antimicrobial agent.

### Claim 21 (depends on 1)

The device of claim 1, wherein at least a portion of the outer surface is composed of a material comprising a gastric-acid resistant material.

### Claim 22 (depends on 1)

The device of claim 1, wherein the casing comprises an ultrasonically visible marker for ultrasonically monitoring the device in vivo.

### Claim 23

An intragastric device, comprising:
a flexible and expandable bladder having a biocompatible outer surface and, upon expansion, a predetermined shape for contacting the antrum of the stomach of a subject; and,
a means for expanding the bladder in vivo; wherein,
the flexible bladder has
a diameter upon expansion that ranges from about 40 mm to about 80 mm; and,
a high specific gravity material, wherein the high specific gravity material contributes to an in vivo specific gravity of the device that ranges from about 1.2 g/ml to about 2.1 g/ml and functions to direct the device to the pyloric antrum of the subject during use of the device.

### Claim 24 (depends on 23)

The device of claim 23, wherein the bladder has a predetermined shape designed to apply a pressure to the pyloric antrum to satiate hunger in the subject.

### Claim 25 (depends on 23)

The device of claim 23, wherein the device has an in vivo specific gravity ranging from about 1.3 g/ml to about 1.6 g/ml.

### Claim 26 (depends on 23)

The device of claim 23, wherein the device has an in vivo specific gravity ranging from about 1.2 g/ml to about 1.3 g/ml.

### Claim 27 (depends on 23)

The device of claim 23, wherein a portion of the outer surface is compliant or substantially compliant with a surface of the antrum and has a durometer of at least about Shore 40A.

### Claim 28 (depends on 23)

The device of claim 23, wherein the casing comprises an ultrasonically visible marker for ultrasonically monitoring the device in vivo.

### Claim 29

An untethered, high specific gravity, hydrogel-containing, intragastric device that is at least substantially leakproof, wherein the device comprises:
an expandable casing having a biocompatible outer surface, an inner compartment, and a sealable port in communication with the inner compartment for expanding the casing in vivo; wherein, the casing has
a minimal dimension ranging from about 40 mm to about 80 mm during operation of the device in a subject to avoid passage of any portion of the device through the lower esophageal sphincter or pyloric sphincter of the subject; and,
an aspect ratio ranging from about 1:1 to about 2:1 during operation of the device;
a high specific gravity material, wherein the high specific gravity material contributes to a specific gravity during use that ranges from about 1.2 g/ml to about 2.1 g/ml, wherein the specific gravity functions to direct the device to the antrum of the stomach of the subject during use of the device;
and,
a hydrogel material;
wherein, the intragastric device is at least substantially leakproof, functioning to provide a volume sufficient to avoid passage of any portion of the device through the lower esophageal sphincter or pyloric sphincter of the subject for a period of at least 9 months.

### Claim 30 (depends on 29)

The device of claim 29, wherein the device has an in vivo specific gravity ranging from about 1.3 g/ml to about 1.6 g/ml.

### Claim 31 (depends on 29)

The device of claim 29, wherein the device has an in vivo specific gravity ranging from about 1.2 g/ml to about 1.3 g/ml.

### Claim 32 (depends on 29)

The device of claim 29, wherein the inner compartment contains the high specific gravity material.

### Claim 33 (depends on 29)

The device of claim 29, wherein the casing comprises the high specific gravity material.

### Claim 34 (depends on 29)

The device of claim 29, wherein the high specific gravity material is contained by the inner compartment and integrated with the casing.

### Claim 35 (depends on 29)

The device of claim 29, wherein the outer surface of the casing comprises the high specific gravity material.

### Claim 36 (depends on 29)

The device of claim 29, wherein at least a portion of the outer surface is composed of a material comprising a gastric-acid resistant, low friction material.

### Claim 37 (depends on 29)

The device of claim 29, wherein the device further comprises a surface that is compliant or substantially compliant with a surface of the antrum.

### Claim 38 (depends on 29)

The device of claim 29, wherein a portion of the outer surface is compliant or substantially compliant with a surface of the antrum having a durometer of at least about Shore 40A.

### Claim 39 (depends on 29)

The device of claim 29, wherein the casing comprises an ultrasonically visible marker for ultrasonically monitoring the device in vivo.

### Claim 40

An untethered, high specific gravity, antrum-based, intragastric device, comprising:
an expandable casing having a biocompatible outer surface and, upon expansion, a predetermined shape for contacting the antrum of the stomach of a subject; wherein,
the expanded casing has
a minimum, cross-sectional dimension of at least about 40 mm during operation of the device in the subject to avoid passage of any portion of the device through the lower esophageal sphincter or pyloric sphincter of the subject after expansion;
a maximum, cross-sectional dimension of the predetermined shape of about 80 mm for a positioning of the predetermined shape in the pyloric antrum of the subject;
and,
a filling material comprising a biocompatible fluid component and a hydrogel component, wherein the filling material has a specific gravity greater than 1.2 g/ml and contributes to an in vivo specific gravity of the device that ranges from about 1.2 g/ml to about 2.1 g/ml, the specific gravity functioning to direct the device to the pyloric antrum of the subject during use of the device.

### Claim 41 (depends on 40)

The device of claim 40, wherein the device has an in vivo specific gravity ranging from about 1.3 g/ml to about 1.6 g/ml.

### Claim 42 (depends on 40)

The device of claim 40, wherein the device has an in vivo specific gravity ranging from about 1.2 g/ml to about 1.3 g/ml.

### Claim 43 (depends on 40)

The device of claim 40, wherein the biocompatible fluid is selected from the group consisting of a salt solution, a sugar solution, honey, a sugar alcohol solution, glycerin, or a combination thereof.

### Claim 44 (depends on 40)

The device of claim 40, wherein the biocompatible fluid comprises a sugar alcohol solution.

### Claim 45 (depends on 40)

The device of claim 40, wherein the casing comprises an ultrasonically visible marker for ultrasonically monitoring the device in vivo.

### Claim 46

An intragastric device, comprising:
a flexible and expandable bladder having a predetermined shape upon expansion for contacting the antrum of the stomach of a subject; wherein,
the device is designed to avoid passage of any part of the device beyond the pylorus and lower esophageal sphincter while the bladder is expanded during use in vivo;
the bladder has a high specific gravity material when expanded;
the high specific gravity material contributes to an in vivo specific gravity of the device that ranges from about 1.2 g/ml to about 2.1 g/ml and functions to direct the device to the pyloric antrum of the subject during use of the device;
and,
a filling material comprising a biocompatible fluid component and a hydrogel component, wherein the filling material has a specific gravity greater than 1.2 g/ml;
wherein, the intragastric device is at least substantially leakproof, functioning to provide a volume sufficient to avoid passage of any portion of the device through the lower esophageal sphincter or pyloric sphincter of the subject for a period of at least 9 months.

### Claim 47 (depends on 46)

The device of claim 46, wherein the device has an in vivo specific gravity ranging from about 1.3 g/ml to about 1.6 g/ml.

### Claim 48 (depends on 46)

The device of claim 46, wherein the device has an in vivo specific gravity ranging from about 1.2 g/ml to about 1.3 g/ml.

### Claim 49 (depends on 46)

The device of claim 46, wherein the biocompatible fluid is selected from the group consisting of a salt solution, a sugar solution, honey, a sugar alcohol solution, glycerin, or a combination thereof.

### Claim 50 (depends on 46)

The device of claim 46, wherein the biocompatible fluid comprises a sugar alcohol solution.

### Claim 51 (depends on 46)

The device of claim 46, wherein the casing comprises an ultrasonically visible marker for ultrasonically monitoring the device in vivo.

### Claim 52 (depends on 1)

A method of administering the device of claim 1, comprising:
placing the device in a collapsed state in the stomach of the subject; and,
expanding the device after the placing; wherein,
the high specific gravity functions to direct the device to the antrum of the stomach.

### Claim 53 (depends on 23)

A method of administering the device of claim 23, comprising:
placing the device in a collapsed state in the stomach of the subject; and,
expanding the device after the placing; wherein,
the high specific gravity functions to direct the device to the antrum of the stomach.

### Claim 54 (depends on 29)

A method of administering the device of claim 29, comprising:
placing the device in a collapsed state in the stomach of the subject; and,
expanding the device after the placing; wherein,
the high specific gravity functions to direct the device to the antrum of the stomach.

### Claim 55 (depends on 40)

A method of administering the device of claim 40, comprising:
placing the device in a collapsed state in the stomach of the subject; and,
expanding the device after the placing; wherein,
the high specific gravity functions to direct the device to the antrum of the stomach.

### Claim 56 (depends on 46)

A method of administering the device of claim 46, comprising:
placing the device in a collapsed state in the stomach of the subject; and,
expanding the device after the placing; wherein,
the high specific gravity functions to direct the device to the antrum of the stomach.

### Claim 57 (depends on 1)

A method of treating obesity in a subject using the device of claim 1, wherein the method comprises:
placing the device in a collapsed state in the stomach of the subject;
expanding the device; and,
treating the subject for an effective amount of time.

### Claim 58 (depends on 57)

The method of claim 57, wherein, the treating includes a deployment period of at least 9 months.

### Claim 59 (depends on 23)

A method of treating obesity in a subject using the device of claim 23, wherein the method comprises:
placing the device in a collapsed state in the stomach of the subject;
expanding the device; and,
treating the subject for an effective amount of time.

### Claim 60 (depends on 59)

The method of claim 59, wherein, the treating includes a deployment period of at least 9 months.

### Claim 61 (depends on 29)

A method of treating obesity in a subject using the device of claim 29, wherein the method comprises:
placing the device in a collapsed state in the stomach of the subject;
expanding the device; and,
treating the subject for an effective amount of time.

### Claim 62 (depends on 61)

The method of claim 61, wherein, the treating includes a deployment period of at least 9 months.

### Claim 63 (depends on 40)

A method of treating obesity in a subject using the device of claim 40, wherein the method comprises:
placing the device in a collapsed state in the stomach of the subject;
expanding the device; and,
treating the subject for an effective amount of time.

### Claim 64 (depends on 63)

The method of claim 63, wherein, the treating includes a deployment period of at least 9 months.

### Claim 65 (depends on 46)

A method of treating obesity in a subject using the device of claim 46, wherein the method comprises:
placing the device in a collapsed state in the stomach of the subject;
expanding the device; and,
treating the subject for an effective amount of time.

### Claim 66 (depends on 65)

The method of claim 65, wherein, the treating includes a deployment period of at least 9 months.

### Claim 67 (depends on 1)

A kit comprising the device of claim 1, a filling material having a specific gravity of greater than 1.2 g/ml, and an insertion catheter designed for administration of the device in the subject.

### Claim 68 (depends on 23)

A kit comprising the device of claim 23, a filling material having a specific gravity of greater than 1.2 g/ml, and an insertion catheter designed for administration of the device in the subject.

### Claim 69 (depends on 29)

A kit comprising the device of claim 29, a filling material having a specific gravity of greater than 1.2 g/ml, and an insertion catheter designed for administration of the device in the subject.

### Claim 70 (depends on 40)

A kit comprising the device of claim 40, a filling material having a specific gravity of greater than 1.2 g/ml, and an insertion catheter designed for administration of the device in the subject.

### Claim 71 (depends on 46)

A kit comprising the device of claim 46, a filling material having a specific gravity of greater than 1.2 g/ml, and an insertion catheter designed for administration of the device in the subject.
